ACT (Enact Holdings) Research & Development: $0 Mil (TTM As of Mar. 2026)


ACT Enact Holdings Inc ACT
77 GF Score
Price $44.38
GF Value $38.39
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Enact Holdings Research & Development?

Enact Holdings ACT +0.29% 77 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates ACT with a GF Score™ of 77/100 and a GF Value™ of $38.39 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Enact Holdings's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Enact Holdings  (NAS:ACT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Enact Holdings Research & Development Related Terms

Enact Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Enact Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enact Holdings Research & Development Chart

Enact Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Enact Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ACT
77GF Score
Enact Holdings Inc ACT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enact Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Enact Holdings (ACT) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Enact Holdings and its competitors.
Is Enact Holdings' Research & Development too high?
Enact Holdings' current Research & Development is $0 Mil. Overall, Enact Holdings has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Enact Holdings' Research & Development compare to ESNT and MTG?
Enact Holdings' Research & Development of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Enact Holdings and its competitors. Enact Holdings's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enact Holdings stock overvalued right now?
Based on GuruFocus' analysis, Enact Holdings (ACT) is currently considered Modestly Overvalued. The stock's GF Value™ is $38.39, compared to a current price of $44.38 — trading 15.6% above its estimated fair value. The current Research & Development is $0 Mil. Enact Holdings' overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Enact Holdings (ACT), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enact Holdings (ACT) Overvalued in 2026?

Based on GuruFocus' analysis, Enact Holdings stock appears to be overvalued. The current stock price of $44.38 is trading 15.6% above its estimated GF Value™ of $38.39. GuruFocus considers Enact Holdings to be Modestly Overvalued.

Key valuation signals for ACT:

  • Research & Development: $0 Mil
  • GF Value™: $38.39 vs. price of $44.38 (15.6% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enact Holdings Business Description

Address 8325 Six Forks Road, Raleigh, NC, USA, 27615
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
77GF Score

Get the complete analysis for ACT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$44.38
Price
$38.39
GF Value